Summary of Rheinmetall Investor and Analyst Recap Call (February 04, 2026) Company Overview - **Company**: Rheinmetall (OTCPK:RNMB.F) - **Industry**: Defense and Automotive Key Points Financial Performance and Expectations - **2025 Defense Business Growth**: Expected growth in the defense business is projected to be between **30%-35%**, with margins anticipated in the range of **18.5%-19%** [2][4] - **2026 Revenue Projections**: The defense business is expected to generate revenues of **EUR 15-16 billion**, including the NVL business, with a cash conversion rate anticipated to be very high due to significant orders [3][4] - **Order Intake for 2026**: Total order intake is expected to be around **EUR 80 billion**, with **EUR 67 billion** coming from German orders over the next four quarters [6][7][12] Major Contracts and Orders - **Boxer Contract**: The largest contract signed is the **EUR 12.5 billion** fixed contract for Boxers, to be executed by **2030**, with an option for an additional **EUR 25 billion** from **2030-2035** [5][12] - **Naval Contracts**: Anticipated orders for naval business (F126 and F127) are expected to total around **EUR 12-13 billion** [5][6] - **Ukrainian Orders**: An additional **EUR 3 billion** is expected from Ukrainian customers over the next quarters [7] Cash Flow and Financial Health - **Cash Flow**: Cash flow has been strong due to customer prepayments, with expectations of being **net debt-free** by the end of 2025 and continuing a positive cash environment into 2026 [3][8][41] - **Advance Payments**: The Boxer contract allows for advance payments of up to **30%** on the first **EUR 12.5 billion**, contributing to a strong cash position [8][12] Operational Insights - **Ammunition Business Growth**: The ammunition segment is expected to grow significantly, with revenues projected to increase from **EUR 3.5 billion to around EUR 5 billion** in 2026 [27][70] - **Production Capacity**: The company is enhancing production capacity in various locations, including South Africa, Spain, and Germany, to meet growing demand [27][33] Strategic Outlook - **Long-term Orders**: The company anticipates that Germany will place around **EUR 500 billion** in orders over the next **10-15 years**, with **EUR 67 billion** expected in 2026 alone [12][13] - **Framework Contracts**: The expectation is to convert existing framework contracts into fixed contracts, which will not increase the total backlog in 2026 but will fulfill existing commitments [60][63] Additional Notes - **Operational Efficiency**: Rheinmetall is focusing on increasing efficiency by dedicating production lines between KMW and Rheinmetall [15] - **Future Contracts**: The company is preparing for additional contracts that will support its growth trajectory, particularly in the ammunition sector [60][63] This summary encapsulates the key insights and projections discussed during the investor and analyst recap call, highlighting Rheinmetall's strategic direction and financial expectations for the upcoming years.

Core Viewpoint - China Liansu (02128) has seen its stock price increase over 30% year-to-date, with a recent rise of 6.15% to HKD 6.21, and a trading volume of HKD 97.15 million [1] Group 1: Financial Performance - Citigroup's recent report indicates a downward revision of China Liansu's earnings forecast for 2026 to 2028 by 11% to 18%, reflecting impairments in non-core projects [1] - The company's core business in mainland China shows signs of stabilization, with reduced drag from residential operations, offset by strong growth in non-residential sectors such as agriculture, industry, healthcare, and municipal services [1] - Citigroup projects a 10% year-on-year decline in core net profit for the second half of last year to RMB 938 million, with a 13% decline compared to the first half, and a slight decrease in net profit margin from 8.7% to 7.4% [1] Group 2: Valuation and Investment Outlook - Citigroup has set a target price for China Liansu at HKD 7, up from HKD 6.5, based on a forecasted price-to-earnings ratio of 9 times, which is 0.5 standard deviations above the historical average [1] - The overseas pipeline business of China Liansu is expected to be a major growth driver, with sales growth anticipated to exceed 50% this year [1] - The stock has recently appreciated approximately 20% amid positive sentiment, and any potential pullbacks are viewed as buying opportunities [1]

Group 1 - The core viewpoint of the article highlights that China Tobacco Hong Kong (06055) has seen a stock increase of over 3%, currently trading at HKD 39.84 with a transaction volume of HKD 20.525 million [1] - Recently, China Tobacco Hong Kong signed a tobacco sales framework agreement with Leaf Trading, with annual transaction limits set at HKD 670 million, HKD 840 million, and HKD 980 million for the years 2026-2028 [1] - The company also entered into a framework agreement with China Tobacco International (North America) to export leaf products to new regions, increasing the annual transaction limit [1] Group 2 - According to Cinda Securities, it is expected that due to seasonal factors, leaf imports will remain stable in the second half of 2025, while exports are likely to continue the growth trend seen in the first half [1] - The growth of cigarette exports and Brazilian operations is anticipated to accelerate, with new cigarette products showing signs of recovery [1] - Cinda Securities believes that the significant adjustment of transaction limits by China Tobacco Hong Kong reflects the company's confidence in future business growth [1] Group 3 - The procurement agreements are expected to provide constructive support for the export of leaf products to Southeast Asia, aiding in the diversification of customer structures and attracting more potential buyers from broader regions [1] - The company aims to gradually expand beyond exclusive sales regions by securing high-quality raw material supplies, thereby enhancing its growth potential [1]

Core Viewpoint - China Tobacco Hong Kong (06055) has seen a stock increase of over 3%, currently at HKD 39.84, with a trading volume of HKD 20.525 million, following the signing of significant sales framework agreements [1] Group 1: Sales Agreements - China Tobacco Hong Kong has signed a tobacco sales framework agreement with Leaf Trading, with annual transaction limits set at HKD 670 million, HKD 840 million, and HKD 980 million for the years 2026 to 2028 [1] - The company has also signed a framework agreement with China Tobacco International (North America) for the export of leaf products to new regions, increasing the annual transaction limit [1] Group 2: Market Outlook - According to Cinda Securities, the import of leaf tobacco is expected to remain stable in the second half of 2025 due to seasonal effects, while exports are likely to continue the growth trend observed in the first half [1] - The growth of cigarette exports and Brazilian operations is anticipated to accelerate, with new product performance showing signs of recovery [1] Group 3: Business Confidence - Cinda Securities believes that the significant adjustment of transaction limits by China Tobacco Hong Kong reflects the company's strong confidence in future business growth [1] - The procurement agreements are expected to provide constructive support for the export of leaf products to Southeast Asia, aiding in the diversification of customer structure and attracting a broader range of potential buyers [1] - The company aims to bind high-quality raw material supplies, gradually expanding beyond exclusive sales regions, thereby enhancing its growth potential [1]

Core Viewpoint - Via Biotechnology (01873) announced that its wholly-owned subsidiary, Zhejiang Langhua Pharmaceutical Co., Ltd., received a response from the Taizhou Ecological Environment Bureau regarding the environmental impact report for the production of several peptides and other small molecule drug intermediates [1] Group 1 - The response approved Langhua Pharmaceutical's plan to renovate three existing factories in the Zhejiang Chemical Raw Material Pharmaceutical Base, Linhai Park, to produce high-level intermediates for peptides and other small molecule drugs [1] - Langhua Pharmaceutical intends to implement the production plan outlined in the environmental impact report and comply with the requirements set forth in the response, as well as relevant laws and regulations [1] - The production plan is expected to promote business growth, increase production capacity, and benefit the group [1]

Core Viewpoint - Viatris (01873.HK) announced that its wholly-owned subsidiary, Zhejiang Langhua Pharmaceutical Co., Ltd., received a response from the Taizhou Ecological Environment Bureau regarding the environmental impact report for the proposed production of certain peptides and other small molecule drug intermediates [1] Group 1 - The response approved Langhua Pharmaceutical's plan to renovate three existing factories in the chemical raw material drug base in the Linhai area of Zhejiang Province for the production of peptide and other small molecule drug intermediates [1] - Langhua Pharmaceutical intends to implement the production plan outlined in the environmental impact report and manage the project in accordance with the relevant requirements and applicable laws and regulations [1] - The production plan is expected to promote business growth, increase production capacity, and benefit the group [1]

Core Viewpoint - The company anticipates a net loss of 98 million to 120 million yuan for the year 2025, with a projected net loss excluding non-recurring gains and losses ranging from 120 million to 140 million yuan, indicating a significant improvement compared to the previous year despite the ongoing losses [1] Group 1: Performance Factors - The company has maintained stable cooperation with existing integrated circuit and key component customers while actively adjusting its product and customer structure, leading to an increase in sales volume, revenue, and gross profit of key integrated circuit components compared to the same period last year [1] - The company has achieved a substantial year-on-year increase in sales revenue and gross profit margin for its anode materials business, driven by growth in sales volume and prices, as well as continuous optimization of product formulas and improvements in production efficiency [1] - The company recorded a one-time expense of 58.6552 million yuan related to the termination of an equity incentive plan by its subsidiary Inner Mongolia Snow, which impacted the previous year's performance [1] Group 2: Financial Adjustments - The company expects a reduction in asset impairment losses of approximately 52 million yuan compared to the previous year, primarily due to decreased inventory write-downs and development expenditure impairments [1] - The estimated amount of non-recurring gains and losses for the reporting period is around 23 million yuan, mainly from government subsidies [1]

Group 1 - The core point of the article is that Hangfa Technology (sh600391) reached its daily limit with a price of 53.12 yuan, reflecting a 10% increase and a total market capitalization of 17.536 billion yuan, driven by governance optimization and business growth in the aviation engine sector [1] Group 2 - The company is undergoing a governance structure transformation and business adjustment, implementing multiple governance systems and eliminating the supervisory board, which is expected to benefit long-term development despite potential short-term execution challenges [1] - The expected scale of related transactions for 2026 is 5.87 billion yuan, indicating business growth, with a focus on the core aviation engine business supported by 12 technical teams dedicated to research and development [1] - The aviation engine industry is experiencing sustained demand growth, with increasing national emphasis and investment in the aerospace sector, providing a favorable external environment for the company's business development [1] Group 3 - Technical analysis shows that on January 20, 2026, the stock was included in the "Dragon and Tiger List," with a transaction volume of 747 million yuan, indicating significant buying interest from retail investors, institutions, and foreign capital [1] - The stock price is expected to break through previous resistance levels, attracting more capital inflow [1]

Core Viewpoint - The company expects significant growth in revenue and net profit for the fiscal year 2025, indicating a strong performance outlook despite some challenges in net profit margins [2] Revenue Projections - The company anticipates achieving an operating revenue of approximately 48,000.00 million yuan in 2025, representing a year-on-year growth of about 37.97% [2] - After excluding non-core and non-commercially substantive revenue, the expected operating revenue is around 43,000.00 million yuan [2] Profit Expectations - The projected net profit attributable to shareholders for 2025 is approximately 11,000.00 million yuan, which reflects a substantial increase of about 264.05% compared to the previous year [2] - The expected net profit attributable to shareholders, after deducting non-recurring gains and losses, is approximately -1,300.00 million yuan, indicating a narrowing of losses by about 64.37% year-on-year [2] Strategic Focus - The company is committed to its development strategy, focusing on core business segments to enhance quality and efficiency while actively exploring new growth opportunities [2] - The increase in the fair value of financial assets held by its subsidiary, Jiangsu High-tech Industry Investment Co., Ltd., has significantly contributed to the company's profits during the reporting period [2]

Core Viewpoint - Cummins announced leadership changes in its Power Systems Division to enhance business growth and organizational capabilities, effective February 1, 2026 [1][5]. Group 1: Leadership Changes - Xiang Yongdong, the current General Manager of Cummins Power Systems Division in China, will become the Global Supply Chain Executive Director, recognizing his contributions to nearly 10% annual compound sales growth during his tenure [3][5]. - Yuan Jun, the current General Manager of Chongqing Cummins Engine Co., will succeed Xiang as the General Manager of Cummins Power Systems Division in China, reporting directly to Nathan Stoner, Vice President of Cummins Global and Chairman of Cummins China [5]. Group 2: Responsibilities and Achievements - In his new role, Xiang will lead key supply chain initiatives and collaborate with local and global stakeholders to drive product localization, ensuring alignment with strategic directions set by business line and global supply chain leaders [3][5]. - Yuan Jun will oversee overall operations, strategic planning, business development, team management, and customer relationship building in the China Power Systems Division, leveraging his extensive operational and management experience [5]. - Yuan has a strong track record in revenue generation, production capacity, technological innovation, and team building, having held various significant positions since joining Cummins in 2009 [5].